US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Patent 9200007 was granted and assigned to Karus Therapeutics on December, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 19, 2010
0
Date of Patent
December 1, 2015
0
Patent Application Number
13388164
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.